217 related articles for article (PubMed ID: 8625302)
1. BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines.
Jaworski DM; Kelly GM; Piepmeier JM; Hockfield S
Cancer Res; 1996 May; 56(10):2293-8. PubMed ID: 8625302
[TBL] [Abstract][Full Text] [Related]
2. Brain enriched hyaluronan binding (BEHAB)/brevican increases aggressiveness of CNS-1 gliomas in Lewis rats.
Nutt CL; Zerillo CA; Kelly GM; Hockfield S
Cancer Res; 2001 Oct; 61(19):7056-9. PubMed ID: 11585735
[TBL] [Abstract][Full Text] [Related]
3. Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas.
Viapiano MS; Bi WL; Piepmeier J; Hockfield S; Matthews RT
Cancer Res; 2005 Aug; 65(15):6726-33. PubMed ID: 16061654
[TBL] [Abstract][Full Text] [Related]
4. Intracranial injury acutely induces the expression of the secreted isoform of the CNS-specific hyaluronan-binding protein BEHAB/brevican.
Jaworski DM; Kelly GM; Hockfield S
Exp Neurol; 1999 Jun; 157(2):327-37. PubMed ID: 10364444
[TBL] [Abstract][Full Text] [Related]
5. BEHAB/brevican: an extracellular matrix component associated with invasive glioma.
Gary SC; Hockfield S
Clin Neurosurg; 2000; 47():72-82. PubMed ID: 11197728
[TBL] [Abstract][Full Text] [Related]
6. Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member.
Matthews RT; Gary SC; Zerillo C; Pratta M; Solomon K; Arner EC; Hockfield S
J Biol Chem; 2000 Jul; 275(30):22695-703. PubMed ID: 10801887
[TBL] [Abstract][Full Text] [Related]
7. Expression of a cleaved brain-specific extracellular matrix protein mediates glioma cell invasion In vivo.
Zhang H; Kelly G; Zerillo C; Jaworski DM; Hockfield S
J Neurosci; 1998 Apr; 18(7):2370-6. PubMed ID: 9502798
[TBL] [Abstract][Full Text] [Related]
8. Glial tumor invasion: a role for the upregulation and cleavage of BEHAB/brevican.
Nutt CL; Matthews RT; Hockfield S
Neuroscientist; 2001 Apr; 7(2):113-22. PubMed ID: 11496922
[TBL] [Abstract][Full Text] [Related]
9. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
Mäenpää A; Junnikkala S; Hakulinen J; Timonen T; Meri S
Am J Pathol; 1996 Apr; 148(4):1139-52. PubMed ID: 8644856
[TBL] [Abstract][Full Text] [Related]
10. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.
Rosenzweig T; Ziv-Av A; Xiang C; Lu W; Cazacu S; Taler D; Miller CG; Reich R; Shoshan Y; Anikster Y; Kazimirsky G; Sarid R; Brodie C
Cancer Res; 2006 Apr; 66(8):4139-48. PubMed ID: 16618735
[TBL] [Abstract][Full Text] [Related]
11. A novel membrane-associated glycovariant of BEHAB/brevican is up-regulated during rat brain development and in a rat model of invasive glioma.
Viapiano MS; Matthews RT; Hockfield S
J Biol Chem; 2003 Aug; 278(35):33239-47. PubMed ID: 12799382
[TBL] [Abstract][Full Text] [Related]
12. [Expression of SV40Tag, Rb and IRS-1 in glioma detected by tissue microarray and their relation with tumorigenesis and progression of gliomas].
Qian ZY; Wu YY; Huang Q; Zhai DZ; Zhu Q; Wang AD; Huo HM; Lan Q
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):432-6. PubMed ID: 19024517
[TBL] [Abstract][Full Text] [Related]
13. Expression of p33ING1 mRNA and chemosensitivity in brain tumor cells.
Tallen G; Riabowol K; Wolff JE
Anticancer Res; 2003; 23(2B):1631-5. PubMed ID: 12820433
[TBL] [Abstract][Full Text] [Related]
14. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
Kong L; Li Q; Wang L; Liu Z; Sun T
Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
[TBL] [Abstract][Full Text] [Related]
15. Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.
Konduri SD; Osman FA; Rao CN; Srinivas H; Yanamandra N; Tasiou A; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Kouraklis G; Rao JS
Oncogene; 2002 Jan; 21(6):921-8. PubMed ID: 11840337
[TBL] [Abstract][Full Text] [Related]
16. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
[TBL] [Abstract][Full Text] [Related]
17. BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.
Viapiano MS; Hockfield S; Matthews RT
J Neurooncol; 2008 Jul; 88(3):261-72. PubMed ID: 18398576
[TBL] [Abstract][Full Text] [Related]
18. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity.
Yamamoto H; Swoger J; Greene S; Saito T; Hurh J; Sweeley C; Leestma J; Mkrdichian E; Cerullo L; Nishikawa A; Ihara Y; Taniguchi N; Moskal JR
Cancer Res; 2000 Jan; 60(1):134-42. PubMed ID: 10646865
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients.
Genkai N; Homma J; Sano M; Tanaka R; Yamanaka R
Oncol Rep; 2006 Jun; 15(6):1569-74. PubMed ID: 16685397
[TBL] [Abstract][Full Text] [Related]
20. An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor.
Kambara H; Okano H; Chiocca EA; Saeki Y
Cancer Res; 2005 Apr; 65(7):2832-9. PubMed ID: 15805284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
